MARKET

BCTXZ

BCTXZ

Briacell Therapeutics Corp
NASDAQ
0.1400
0.00
0.00%
Opening 09:30 04/01 EDT
OPEN
--
PREV CLOSE
0.1400
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
1.515
52 WEEK LOW
0.0551
MARKET CAP
--
P/E (TTM)
-0.0043
1D
5D
1M
3M
1Y
5Y
1D
BriaPro buys BriaCell soluble CD80 cancer therapy license, BriaCell stake rises to 78%
Reuters · 1d ago
BriaCell to present four posters at the AACR Annual Meeting
Reuters · 03/18 11:30
BriaCell reports 9 of 25 Phase 2 metastatic breast cancer patients alive more than 18-47 months post-enrollment
Reuters · 03/17 14:32
BriaCell to present four posters at the AACR Annual Meeting
Reuters · 03/10 11:53
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
Barchart · 03/10 06:30
BriaPro to Buy BriaCell’s Exclusive Soluble CD80 License in Asset Deal
Reuters · 02/20 21:01
BriaPro to Buy BriaCell’s Exclusive Soluble CD80 License in Asset Deal
Reuters · 02/18 22:30
BRIACELL THERAPEUTICS CORP: AS PART OF TRANSACTION, BRIACELL WILL MAKE AVAILABLE TO BRIAPRO UP TO $3 MLN TO FUND RESEARCH AND DEVELOPMENT EFFORT
Reuters · 02/18 22:30
More

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTXZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTXZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTXZ stock methods without spending real money on the virtual paper trading platform.